Differential pharmacokinetics of digoxin in elderly patients

Drugs and Aging

Volumn 17, Issue 5, 2000, Pages 353-362

  Hanratty, Colm G ^a   McGlinchey, Paul ^a   Johnston, G Dennis ^a   Passmore, A Peter ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMILORIDE; AMIODARONE; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CARVEDILOL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; EPANOLOL; EPROSARTAN; ESMOLOL; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; MEXILETINE; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PROCAINAMIDE; QUINIDINE; RAMIPRIL; TRIAMTERENE; UNINDEXED DRUG; VERAPAMIL;

AGED; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INDICATION; DRUG SAFETY; ELDERLY CARE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MORBIDITY; MORTALITY; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW;

EID: 0033647312     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200017050-00003     Document Type: Review

References (87)

1. Determinants of drug utilisation in an elderly population in North and West Belfast
2. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides
3. Intestinal absorption of digoxin-3H in the rat
4. Digoxin in the elderly: Pharmacokinetic consequences of old age
5. Digoxin toxicity in the aged: Characterising and avoiding the problem
6. Digoxin pharmacokinetics: Multi-compartmental analysis and its clinical implications
7. Inhibition of the intestinal digoxin absorption and exsorption by quinidine
8. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin
9. Pharmacokinetic and pharmacodynamic changes in the elderly: Clinical implications
10. The effect of ageing on drug absorption from the gut
11. The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study
12. Prediction of creatinine clearance from serum creatinine
13. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
14. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE Study
15. The effect of digoxin on mortality and morbidity in patients with heart failure
16. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: A randomized, double-blinded trial
17. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation
18. Clinical pharmacokinetics in heart failure: An updated review
19. Cardiovascular drugs in the elderly
20. Effect of furosemide on the renal excretion of digoxin
21. Effect of chronic potassium depletion on digitalis-induced inotropy and arrhythmias
22. Digoxin toxicity compared with myocardial digoxinand potassium concentration
23. Interactions between digoxin and potassium-sparing diuretics
24. Digoxin-interactions in man: Spironolactone reduces renal but not biliary digoxin clearance
25. The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failure
26. The effect of captopril on pharmacokinetics of digoxin in patients with mild congestive heart failure
27. Pharmacokinetic interaction study with ramipril and digoxin in healthy volunteers
28. Digoxin pharmacokinetics and perindopril in heart failure patients
29. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers
30. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers
31. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin
32. Clinical pharmacology of acebutolol
33. Esmolol-digoxin drug interaction
34. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
35. Carvedilol increases the systemic bioavailability of oral digoxin
36. Effect of quinidine on plasma concentrations of digoxin
37. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction
38. Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications
39. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine
40. Quinidine-digoxin interaction: Evidence for involvement of an extrarenal mechanism
41. Digoxin-quinidine interaction in patients with chronic renal failure
42. Quinidine reduces biliary clearance of digoxin in man
43. Quinidine-digoxin interaction: Time course and pharmacokinetics
44. Interaction between quinidine and digoxin
45. Enhanced cardiac effect of digoxin during quinidine treatment
46. A previously unrecognized drug interaction between quinidine and digoxin
47. An electrophysiologic study of the digoxin-quinidine interaction
48. Drug toxicity inpatients receiving digoxin and quinidine
49. Amiodarone increases plasma digoxin concentrations
50. Pharmacokinetic evaluation of the digoxin-amiodarone interaction
51. Amiodarone digoxin interaction: Clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications
52. Amiodarone-induced torsades de pointes: The possible facilitatory role of digoxin
53. The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin: A prospective study
54. Interaction of flecainide with digoxin and propranolol
55. Effect of oral disopyramide on serum digoxin levels: A prospective study
56. Effect of nifedipine on serum digoxin concentration and renal digoxin clearance
57. Verapamil-digoxin interaction
58. Digoxin-verapamil interaction
59. Comparative effects of verapamil and isradipine on steady-state digoxin kinetics
60. Lack of effects of diltiazem on digoxin pharmacokinetics
61. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
62. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
63. Pharmacokinetic effects of fluvastatin in patients chronically receiving digoxin
64. Steady state serum concentrations of pravastatin digoxin when given in combination
65. Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteers
66. Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion
67. Effects of hypocholesterolemic interventions on digoxin bioavailability
68. Digoxin-macrolide drug interaction
69. Digoxin toxicity secondary to clarithromycin therapy
70. Cyclosporin and quinidine inhibition of renal digoxin excretion: Evidence for luminal secretion of digoxin
71. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
72. Kinetics of the digoxin-aspirin combination
73. Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy
74. Interaction between digoxin and indomethacin or ibuprofen
75. Clinical pharmacokinetics of diclofenac: Therapeutic insights and pitfalls
76. An interaction study between benoxaprofen and digoxin
77. Effect of tiaprofenic acid on serum digoxin concentration
78. Pharmacokinetic interactions with digoxin
79. Digoxin and cimetidine: Investigation of the potential for a drug interaction
80. Effect of cimetidine on steady-state serum digoxin concentrations
81. Effect of cimetidine ondigoxin kinetics and creatinine clearance
82. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose
83. Impairment of absorption of digoxin by acarbose
84. Effect of alprazolam on digoxin kinetics and creatinine clearance
85. Age-related digoxin-alprazolam interaction
86. Concurrent administration of donepezil HCl and digoxin: Assessment of pharmacokinetic changes
87. Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithium